We are live on
!
Find out more
BC
Broadwood Capital Portfolio holdings
AUM
$1.42B
1-Year Est. Return
34.72%
This Fund
S&P 500
This Quarter
Est. Return
+37.58%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$440M
AUM Growth
–
Cap. Flow
+$381M
Cap. Flow
% of AUM
86.57%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
+$117M |
| 2 |
Monster Beverage
MNST
|
+$92.3M |
| 3 |
STAAR Surgical
STAA
|
+$51.8M |
| 4 |
Lineage Cell Therapeutics
LCTX
|
+$35.8M |
| 5 |
CYNO
Cynosure, Inc. Class A
CYNO
|
+$20.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.89% |
| 2 | Consumer Staples | 22.67% |
Similar funds
PTC
NI
CBA
KC
EWS
IHG
SCM
PPC
Broadwood Capital's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Broadwood Capital, which disclosed 7 positions worth $440M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is QUESTCOR PHARMA INC: 3,296,660 shares worth $150M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, followed by Consumer Staples.
- Broadwood Capital's largest Q2 2013 buy was QUESTCOR PHARMA INC: 3,296,660 shares worth $150M.
- Broadwood Capital's ten largest holdings make up 100% of its $440M portfolio in Q2 2013.
- Broadwood Capital disclosed 7 positions in Q2 2013, its first 13F filing on record.
Based on Broadwood Capital's 13F filing for Q2 2013, filed 14 Aug 2013.